Literature DB >> 28861802

Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma: What Is More Is About Different Therapeutic Strategies.

Xiaoyun Zhang1, Chuan Li1, Tianfu Wen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28861802     DOI： 10.1007/s11605-017-3553-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

Authors:  Margarita Sala; Josep Fuster; Josep M Llovet; Miquel Navasa; Manel Solé; María Varela; Fernando Pons; Antoni Rimola; Juan Carlos García-Valdecasas; Concepció Brú; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

2.  Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.

Authors:  Bin Wang; Chun-Yan Xia; Wan-Yee Lau; Xin-Yuan Lu; Hui Dong; Wen-Long Yu; Guang-Zhi Jin; Wen-Ming Cong; Meng-Chao Wu
Journal:  J Am Coll Surg       Date:  2013-12       Impact factor: 6.113

3.  Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen; Lunan Yan; Bo Li; Jiayin Yang; Wentao Wang; Mingqing Xu; Wusheng Lu; Li Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-08       Impact factor: 2.566

4.  Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Authors:  Shenghua Hao; Ping Fan; Shaofei Chen; Caixue Tu; Chidan Wan
Journal:  J Gastrointest Surg       Date:  2016-11-04       Impact factor: 3.452

5.  Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.

Authors:  M Matsuda; H Fujii; H Kono; Y Matsumoto
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

6.  Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.

Authors:  Zhenhua Hu; Jie Zhou; Zhiwei Li; Jie Xiang; Ze Qian; Jian Wu; Min Zhang; Shusen Zheng
Journal:  Surgery       Date:  2015-02       Impact factor: 3.982

Review 7.  Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis.

Authors:  Zhenhua Hu; Wei Wang; Zhiwei Li; Sunyi Ye; Shu-Sen Zheng
Journal:  Liver Transpl       Date:  2012-11       Impact factor: 5.799

8.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

9.  Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.

Authors:  Joana Ferrer-Fàbrega; Alejandro Forner; Alexandre Liccioni; Rosa Miquel; Víctor Molina; Miquel Navasa; Constantino Fondevila; Juan Carlos García-Valdecasas; Jordi Bruix; Josep Fuster
Journal:  Hepatology       Date:  2016-01-13       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.